Stay updated on Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel

Sign up to get notified when there's something new on the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page

  1. Check
    7 days ago
    Change Detected
    Summary
    Locations were updated with many new sites across multiple countries and regions and some sites were removed, changing where eligible participants can enroll.
    Difference
    2%
    Check dated 2025-12-19T13:09:59.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    A new site revision tag Revision: v3.3.2 appears, replacing Revision: v3.3.1. This is a minor metadata update and does not affect study details or user-facing content.
    Difference
    0.0%
    Check dated 2025-11-28T02:18:47.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Publications note updated to clarify that PubMed publications are automatically filled from PubMed, and a revision tag now shows v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-20T22:16:30.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page-level funding status notice was removed. The study details, outcomes and locations remain unchanged.
    Difference
    0.1%
    Check dated 2025-11-13T15:52:16.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page; the study details remain unchanged.
    Difference
    0.2%
    Check dated 2025-10-30T11:11:44.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Update: version revision changed from v3.0.2 to v3.2.0.
    Difference
    0.0%
    Check dated 2025-10-01T03:10:21.000Z thumbnail image

Stay in the know with updates to Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel

Enter your email address, and we'll notify you when there's something new on the Clinical Trial HER2+ Breast Cancer Trastuzumab-Paclitaxel page.